Procurement of Imported Plasma and Recombinant Products (IPRP) – Hemlibra (emicizumab)
Grant AT-CN4171505 — Direct Award
Amount
$317,718,917
Selection Process
Direct Award
Period
30 Jun 2025 — 29 Jun 2028
Approved: 18 Jul 2025
Purpose
Procurement method: Limited tender
Other Grants to Roche Products Pty Ltd
| Grant | Program | Amount | Selection |
|---|---|---|---|
| Supply of Hemlibra | National Blood Authority | $353,210,000 | Direct Award |
Data Source
Source: AusTender
Category: UNSPSC 51000000
State: NSW | Postcode: 2000